enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of abbreviations used in medical prescriptions - Wikipedia

   en.wikipedia.org/wiki/List_of_abbreviations_used...

   o 2, o 2 both eyes "O 2" usually means oxygen or oxygen therapy: o.d. omni die: every day (once daily) (preferred to "qd" in the UK [10]) o.d. oculus dexter: right eye o can be mistaken as an a which could read "a.d.", meaning right ear, confusion with "omni die" o.m. omni mane: every morning omn. bih. omni bihora: every 2 hours omn. hor. omni ...

3. Imidacloprid/moxidectin - Wikipedia

   en.wikipedia.org/wiki/Imidacloprid/moxidectin

   This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

4. List of drugs: Pro–Prz - Wikipedia

   en.wikipedia.org/wiki/List_of_drugs:_Pro–Prz

   This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales.

5. List of medical abbreviations: Latin abbreviations - Wikipedia

   en.wikipedia.org/wiki/List_of_medical...

   2 times a day bis die sumendum b.i.d., bid, BID twice a day / twice daily bis in die gtt., gtts drop(s) gutta(e) h., h hour: hora: qhs, h.s., hs at bedtime or half strength quaque hora somni ii two tablets duos doses iii three tablets trēs doses n.p.o., npo, NPO nothing by mouth / not by oral administration: nil per os o.d., od, OD right eye

6. Maropitant - Wikipedia

   en.wikipedia.org/wiki/Maropitant

   Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate (), is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs.

7. Akorn to Acquire Hi-Tech Pharmacal for $640 Million - AOL

   www.aol.com/2013/08/27/akorn-to-acquire-hi-tech...

   Akorn to Acquire Hi-Tech Pharmacal for $640 Million - Over $500 million in combined revenues - - Immediately accretive to non-GAAP earnings, before synergies - - $15-20 million in annual run-rate ...